{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:02:43Z","timestamp":1768453363130,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.trim.2020.101334","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:29:53Z","timestamp":1599686993000},"page":"101334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of re-augmenting maintenance immunosuppression on post-transplant donor-specific HLA antibodies in liver transplantation"],"prefix":"10.1016","volume":"63","author":[{"given":"Kazuaki","family":"Tokodai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehito","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kashiwadate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2020.101334_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2020.101334_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2016.05.020","article-title":"De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome","author":"Le Pavec","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(72)90288-7","article-title":"Immunopathological studies of orthotopic human liver allografts","volume":"299","author":"Andres","year":"1972","journal-title":"Lancet."},{"key":"10.1016\/j.trim.2020.101334_bb0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2020.101334_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2020.101334_bb0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2020.101334_bb0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","article-title":"Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal","volume":"98","author":"Ohe","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2020.101334_bb0040","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant","volume":"11","author":"O\u2019Leary","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0045","article-title":"Impact of the trough level of calcineurin inhibitor on the prevalence of donor-specific human leukocyte antigen antibodies during long-term follow-up after pediatric liver transplantation","volume":"3","author":"Tokodai","year":"2017","journal-title":"Transplant. Direct."},{"key":"10.1016\/j.trim.2020.101334_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13169","article-title":"Association of post-transplant donor-specific HLA antibody with liver graft fibrosis during long-term follow-up after pediatric liver transplantation","volume":"22","author":"Tokodai","year":"2018","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/TP.0b013e318195a7cb","article-title":"Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation","volume":"87","author":"Yoshitomi","year":"2009","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2020.101334_bb0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1399-3046.2012.01781.x","article-title":"Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation","volume":"16","author":"Yamada","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0065","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","author":"Kaneku","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/tri.12654","article-title":"De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients","author":"Del Bello","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2020.101334_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/lt.25177","article-title":"Prevalence, risk factors, and impact of donor-specific alloantibodies after adult liver transplantation","author":"Vandevoorde","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2020.101334_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxy039","article-title":"Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation\/antibody production after kidney transplantation","author":"Iwasaki","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trim.2020.101334_bb0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2020.101334_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2020.101334_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13648","article-title":"Characteristics and predictive value for graft fibrosis of the complement-binding capacity of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation","volume":"24","author":"Tokodai","year":"2020","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2020.101334_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000000796","article-title":"Donor-specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation","author":"Wozniak","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2020.101334_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation","author":"Kaneku","year":"2012","journal-title":"Liver Transpl."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327420301465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327420301465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:59Z","timestamp":1760810399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327420301465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":21,"alternative-id":["S0966327420301465"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2020.101334","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of re-augmenting maintenance immunosuppression on post-transplant donor-specific HLA antibodies in liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2020.101334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101334"}}